Vascular endothelial growth factor (VEGF) is thought to have an important role in the pathogenesis of macular edema[1], and anti-VEGF therapy has been shown to improve macular edema over both the short-term and the long-term[2,3]. Here, VEGFA is linked to macular retinal edema.